Identifying the role of (dis)inhibition in the vicious cycle of substance use through ecological momentary assessment and resting-state fMRI

• Published in: Translational psychiatry 2024-06, Vol.14 (1), p.260-9, Article 260
• Main Authors: Chirokoff, Valentine, Berthoz, Sylvie, Fatseas, Melina, Misdrahi, David, Dupuy, Maud, Abdallah, Majd, Serre, Fuschia, Auriacombe, Marc, Pfefferbaum, Adolf, Sullivan, Edith V., Chanraud, Sandra
• Format: Article
• Language: English
• Subjects: 59/36; 631/477/2811; 692/53/2423; 692/699/476/5; Adult; Alcoholism - diagnostic imaging; Alcoholism - psychology; Behavioral Sciences; Biological Psychology; Case-Control Studies; Cerebellum - diagnostic imaging; Craving; Drug use; Ecological Momentary Assessment; Female; Frontal Lobe - diagnostic imaging; Human health and pathology; Humans; Inhibition, Psychological; Life Sciences; Magnetic Resonance Imaging; Male; Marijuana Abuse - diagnostic imaging; Marijuana Abuse - psychology; Medicine; Medicine & Public Health; Middle Aged; Neurons and Cognition; Neurosciences; Occipital Lobe - diagnostic imaging; Pharmacotherapy; Psychiatrics and mental health; Psychiatry; Psychology and behavior; Self Report; Stroop Test; Tobacco Use Disorder - diagnostic imaging; Tobacco Use Disorder - psychology
• ISSN: 2158-3188; 2158-3188
• DOI: 10.1038/s41398-024-02949-1

Functional inhibition is known to improve treatment outcomes in substance use disorder (SUD), potentially through craving management enabled by underlying cerebral integrity. Whereas treatment is challenged by a multitude of substances that patients often use, no study has yet unraveled if inhibition and related cerebral integrity could prevent relapse from multiples substances, that is, one’s primary drug of choice and secondary ones. Individuals with primary alcohol, cannabis, or tobacco use disorders completed intensive Ecological Momentary Assessment (EMA) coupled with resting-state functional MRI (rs-fMRI) to characterize the extent to which inhibition and cerebral substrates interact with craving and use of primary and any substances. Participants were 64 patients with SUD and 35 healthy controls who completed one week EMA using Smartphones to report 5 times daily their craving intensity and substance use and to complete Stroop inhibition testing twice daily. Subsamples of 40 patients with SUD and 34 control individuals underwent rs-fMRI. Mixed Model Analysis revealed that reported use of any substance by SUD individuals predicted later use of any and primary substance, whereas use of the primary substance only predicted higher use of that same substances. Craving and inhibition level independently predicted later use but did not significantly interact. Preserved inhibition performance additionally influenced use indirectly by mediating the link between subsequent uses and by being linked to rs-fMRI connectivity strength in fronto-frontal and cerebello-occipital connections. As hypothesized, preserved inhibition performance, reinforced by the integrity of inhibitory neurofunctional substrates, may partake in breaking an unhealthy substance use pattern for a primary substance but may not generalize to non-target substances or to craving management.